M. Petretich

1.4k total citations
7 papers, 539 citations indexed

About

M. Petretich is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, M. Petretich has authored 7 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Immunology. Recurrent topics in M. Petretich's work include Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers) and RNA modifications and cancer (2 papers). M. Petretich is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers) and RNA modifications and cancer (2 papers). M. Petretich collaborates with scholars based in Germany, United Kingdom and France. M. Petretich's co-authors include François Spitz, Katja Langenfeld, Veli Vural Uslu, Paola Grandi, Emmanuel H. Demont, Sandra Ruf, Nuno A. Fonseca, John C. Marioni, Ido Amit and Stanley Ng and has published in prestigious journals such as Nature, Nature Genetics and Oncogene.

In The Last Decade

M. Petretich

7 papers receiving 535 citations

Peers

M. Petretich

MB

HEMAT

CR

GENET

ONCOL

Simona Segalla Italy

Todd D. Westergard United States

Alba Maiqués-Díaz United Kingdom

A. Michelle Wallace United States

Andrew Volk United States

Joëlle Michaud Switzerland

Roel Vandepoel Belgium

Carrie Rakowski United States

Agnieszka A. Wendorff United States

Jacqueline Dickson United Kingdom

Simona Segalla Italy

M. Petretich

569 ×1.2

MB

187 ×1.6

HEMAT

69 ×0.7

CR

78 ×1.0

GENET

39 ×0.7

ONCOL

Citations per year, relative to M. Petretich M. Petretich (= 1×) peers Simona Segalla

Countries citing papers authored by M. Petretich

Since Specialization

Citations

This map shows the geographic impact of M. Petretich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Petretich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Petretich more than expected).

Fields of papers citing papers by M. Petretich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Petretich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Petretich. The network helps show where M. Petretich may publish in the future.

Co-authorship network of co-authors of M. Petretich

This figure shows the co-authorship network connecting the top 25 collaborators of M. Petretich. A scholar is included among the top collaborators of M. Petretich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Petretich. M. Petretich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Petretich, M., Emmanuel H. Demont, & Paola Grandi. (2020). Domain-selective targeting of BET proteins in cancer and immunological diseases. Current Opinion in Chemical Biology. 57. 184–193. 41 indexed citations

2.

Watson, Robert J., Paul Bamborough, Heather Barnett, et al.. (2020). GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins. Journal of Medicinal Chemistry. 63(17). 9045–9069. 63 indexed citations

3.

Khoueiry, Pierre, Aoife Ward, M. Petretich, et al.. (2019). BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity. Epigenetics & Chromatin. 12(1). 39–39. 20 indexed citations

4.

Paleske, Lisa von, Veli Vural Uslu, Silvia Remeseiro, et al.. (2018). A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies. Nature. 553(7689). 515–520. 224 indexed citations

5.

Galardi, Silvia, M. Petretich, Guillaume Pinna, et al.. (2016). CPEB1 restrains proliferation of Glioblastoma cells through the regulation of p27Kip1 mRNA translation. Scientific Reports. 6(1). 25219–25219. 25 indexed citations

6.

Uslu, Veli Vural, M. Petretich, Sandra Ruf, et al.. (2014). Long-range enhancers regulating Myc expression are required for normal facial morphogenesis. Nature Genetics. 46(7). 753–758. 102 indexed citations

7.

Meng, Q. W., Gueorgui Kratassiouk, M. Petretich, et al.. (2012). Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression. Oncogene. 31(47). 4960–4966. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact